Fulgent Genetics ( NASDAQ:FLGT ) Full Year 2024 Results Key Financial Results Revenue: US$283.5m (down 2.0% from FY... EL MONTE, Calif., February 28, 2025--Fulgent Genetics, Inc. (NASDAQ ...

Fulgent Genetics, Inc. (FLGT) came out with quarterly earnings of $0.04 per share, beating the Zacks Consensus Estimate of a loss of $0.12 per share. This compares to earnings of $0.28 per share a ...

Paul Kim, the CFO and Treasurer of $FLGT, bought 100,000 shares of the company on 03-05-2025 for an estimated $1,596,470. This trade was reported by Quiver ...

StockNews.com upgraded shares of Fulgent Genetics (NASDAQ:FLGT – Free Report) from a sell rating to a hold rating in a research report released on Wednesday. Separately, Piper Sandler decreased their ...

Q4 2024 Earnings Call Transcript February 28, 2025 Fulgent Genetics, Inc. beats earnings expectations. Reported EPS is $0.04, expectations were $-0.31. Operator: Greetings, and welcome to the Fulgent ...

FLGT has been the topic of several research reports. Piper Sandler dropped their price objective on Fulgent Genetics from $22.00 to $16.00 and set a “neutral” rating on the stock in a report ...

Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Fulgent Genetics (FLGT – Research Report), Alignment ...

Piper Sandler analyst David Westenberg lowered the firm’s price target on Fulgent Genetics (FLGT) to $16 from $22 following quarterly results.